WIN-Partners Co (TSE:3183) ROE % Adjusted to Book Value: 5.96% (As of Mar. 2026)


TSE:3183 WIN-Partners Co Ltd TSE:3183
63 GF Score
Price 円1,285.00
GF Value 円1,522.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is WIN-Partners Co ROE % Adjusted to Book Value?

WIN-Partners Co TSE:3183 +0.31% 63 ROE % Adjusted to Book Value is 5.96% as of Mar. 2026. GuruFocus rates TSE:3183 with a GF Score™ of 63/100 and a GF Value™ of 円1,522.55 (Modestly Undervalued). The stock has 3 warning signs investors should review.

WIN-Partners Co's ROE % for the quarter that ended in Mar. 2026 was 9.65%. WIN-Partners Co's PB Ratio for the quarter that ended in Mar. 2026 was 1.62. WIN-Partners Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 5.96%.

WIN-Partners Co ROE % Adjusted to Book Value Related Terms

WIN-Partners Co ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for WIN-Partners Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WIN-Partners Co ROE % Adjusted to Book Value Chart

WIN-Partners Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.53 7.24 5.34 5.42 5.52

WIN-Partners Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.67 4.92 6.38 5.33 5.96

TSE:3183 vs MCK, CAH, COR: ROE % Adjusted to Book Value Comparison

For the Medical Distribution subindustry, WIN-Partners Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WIN-Partners Co ROE % Adjusted to Book Value vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's ROE % Adjusted to Book Value falls into.


TSE:3183
63GF Score
WIN-Partners Co Ltd TSE:3183
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WIN-Partners Co ROE % Adjusted to Book Value Calculation

WIN-Partners Co's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.95% / 1.62
=5.52%

WIN-Partners Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.65% / 1.62
=5.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 5.96% mean?
WIN-Partners Co (TSE:3183) has a ROE % Adjusted to Book Value of 5.96% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on WIN-Partners Co and its competitors.
Is WIN-Partners Co's ROE % Adjusted to Book Value too high?
WIN-Partners Co's current ROE % Adjusted to Book Value is 5.96%. Overall, WIN-Partners Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's ROE % Adjusted to Book Value compare to MCK and CAH?
WIN-Partners Co's ROE % Adjusted to Book Value of 5.96% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Distribution company?
A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on WIN-Partners Co and its competitors. WIN-Partners Co's current ROE % Adjusted to Book Value is 5.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,522.55, compared to a current price of 円1,285.00 — trading 15.6% below its estimated fair value. The current ROE % Adjusted to Book Value is 5.96%. WIN-Partners Co's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current ROE % Adjusted to Book Value is 5.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WIN-Partners Co (TSE:3183) Overvalued in 2026?

Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued. The current stock price of 円1,285.00 is trading 15.6% below its estimated GF Value™ of 円1,522.55. GuruFocus considers WIN-Partners Co to be Modestly Undervalued.

Key valuation signals for TSE:3183:

  • ROE % Adjusted to Book Value: 5.96%
  • GF Value™: 円1,522.55 vs. price of 円1,285.00 (15.6% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WIN-Partners Co Business Description

Address 2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
63GF Score

Get the complete analysis for TSE:3183

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,285.00
Price
円1,522.55
GF Value